NewsRx

Search our medical news database

Transfusion Medicine

Pre-1990 Blood Products Most Likely To Infect Hemophiliacs With Hepatitis Viruses

Published in Medical Letter on the CDC and FDA, April 22nd, 2001

by Sonia Nichols, staff medical writer - Males with hemophilia are more likely to acquire hepatitis C or B virus (HCV, HBV) infections from blood products made prior to 1990, U.S. Centers for Disease Control and Prevention researchers report.

Patients with hemophilia lack certain clotting factors in the blood, but those factors can be replaced with the use of commercially manufactured blood products. Before 1990, testing procedures for donor blood were not as sensitive for detecting hepatitis viruses as they are now, meaning patients receiving those blood products before 1990 are at a greater risk for developing viral infections.

J. Michael C....

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook